The burden of chronic diseases across Europe: what policies and programs to address diabetes? A SWOT analysis.


Journal

Health research policy and systems
ISSN: 1478-4505
Titre abrégé: Health Res Policy Syst
Pays: England
ID NLM: 101170481

Informations de publication

Date de publication:
29 Jan 2020
Historique:
received: 20 05 2019
accepted: 20 12 2019
entrez: 31 1 2020
pubmed: 31 1 2020
medline: 15 12 2020
Statut: epublish

Résumé

Promoting the well-being at all ages and reducing premature mortality from non-communicable diseases (NCDs) is a major target of the Sustainable Development Goals. In the frame of the JA-CHRODIS, a Strengths, Weaknesses, Opportunities and Threats (SWOT) analysis was conducted to provide different countries' insights on what makes a policy/programme addressing NCDs applicable, sustainable and effective, with a focus on diabetes. A qualitative study has been performed using a SWOT analysis on policies/programmes at the national/federal or subnational level. By March 2016, 14 SWOTs were conducted involving 11 European countries and 57 stakeholders and Ministries of Health, reporting and analysing a total of 44 policies. The main strengths, weaknesses, opportunities and threats have been outlined as well as and the main areas for governance improvement. A binding trans-sectoral approach is necessary to tackle the underlying risk factors of inequalities. The culture of disease prevention and health promotion is still low while the biomedical paradigm prevails. A systematic gender perspective is still missing. Sharing and exchange of best practices, as sponsored by the European Commission, is acting as a motivator. The SWOT analyses draw an overall picture of the complexity of designing and implementing good policies and programmes that are tailored to local needs. These results may apply to any context and can be used by decision-makers, managers, professionals and other stakeholders to focus on key issues, recognising areas for attention.

Sections du résumé

BACKGROUND BACKGROUND
Promoting the well-being at all ages and reducing premature mortality from non-communicable diseases (NCDs) is a major target of the Sustainable Development Goals. In the frame of the JA-CHRODIS, a Strengths, Weaknesses, Opportunities and Threats (SWOT) analysis was conducted to provide different countries' insights on what makes a policy/programme addressing NCDs applicable, sustainable and effective, with a focus on diabetes.
METHODS METHODS
A qualitative study has been performed using a SWOT analysis on policies/programmes at the national/federal or subnational level.
RESULTS RESULTS
By March 2016, 14 SWOTs were conducted involving 11 European countries and 57 stakeholders and Ministries of Health, reporting and analysing a total of 44 policies. The main strengths, weaknesses, opportunities and threats have been outlined as well as and the main areas for governance improvement. A binding trans-sectoral approach is necessary to tackle the underlying risk factors of inequalities. The culture of disease prevention and health promotion is still low while the biomedical paradigm prevails. A systematic gender perspective is still missing. Sharing and exchange of best practices, as sponsored by the European Commission, is acting as a motivator.
CONCLUSION CONCLUSIONS
The SWOT analyses draw an overall picture of the complexity of designing and implementing good policies and programmes that are tailored to local needs. These results may apply to any context and can be used by decision-makers, managers, professionals and other stakeholders to focus on key issues, recognising areas for attention.

Identifiants

pubmed: 31996237
doi: 10.1186/s12961-019-0523-1
pii: 10.1186/s12961-019-0523-1
pmc: PMC6990580
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12

Commentaires et corrections

Type : ErratumIn

Références

BMJ. 2000 Jan 8;320(7227):114-6
pubmed: 10625273
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Ann Ist Super Sanita. 2015;51(3):183-6
pubmed: 26428040
BMJ. 1995 Jul 1;311(6996):42-5
pubmed: 7613329

Auteurs

Angela Giusti (A)

National Centre for Diseases Prevention and Health Promotion, National Institute of Health (Istituto Superiore di Sanità), Viale Regina Elena 299, 00161, Rome, Italy. angela.giusti@iss.it.

Marina Maggini (M)

National Centre for Drug Research and Evaluation, National Institute of Health (Istituto Superiore di Sanità), Viale Regina Elena 299, 00161, Rome, Italy.

Sofia Colaceci (S)

National Centre for Diseases Prevention and Health Promotion, National Institute of Health (Istituto Superiore di Sanità), Viale Regina Elena 299, 00161, Rome, Italy.
Saint Camillus International University of Health and Medical Sciences, Via di Sant'Alessandro 8, 00131, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH